Editer l'article Suivre ce blog Administration + Créer mon blog
Le COVID19 pour les intelligents qui s'ignorent

Le COVID19 pour les intelligents qui s'ignorent

Tout ce que vous voulez savoir sur le covid19 sans jamais oser le demander

Publié le par M. E. DAVID
Publié dans : #Raoultcovid19, #mutationscovid19, #genomecovid19, #geneORF8covid19
Didier Raoult, the eminent infectious disease specialist

Didier Raoult, the eminent infectious disease specialist

Today is the lockdown release day in France, and after several beautiful sunny days, many of us find ourselves back to  greyness and rain. It is as if the weather has been in tune with the mood of the French people, who are called to return back to everyday life with all the stress and anxiety in this context of health crisis. 

I do not have a crystal ball, but the latest studies about the data of new cases, hospitalized people etc, are rather hopeful. Obviously, we will not be able to escape a few clusters (a set of people infected from a single carrier) because the virus is still circulating. However we are more prepared now to be able to test and isolate people carrying covid19, so we can recover to a more serene life.

On Tuesday May 05th, on his morning show, Guillaume Durand interviewed Professor Didier Raoult, the eminent infectious disease specialist. The Professor confirmed that we were nearing the end of the pandemic.

The global epidemic of covid19, he said, comes in the form of a bell curve that is a common shape for the curves of most respiratory infections.

All curves of new cases, whether in France, Europe or in the rest of the world, have much the same shape, with or without lockdown.

According to Professor Didier Raoult, the number of infected people presenting at the IHU of Marseille (University Hospital Institute) is decreasing in Marseille, as well as in France and the rest of the world. The second wave therefore seems unlikely to happen because the data does not go in this direction. All institutes around the world observe the same decrease with these types of bell curves.  

"For reasons that no one understands, epidemic diseases start, they become more and more contagious, then they become more and more serious, then they gradually decrease becoming less and less contagious." This can be observed for most epidemics. 

He has noticed that the virus is currently less contagious and therefore the risk of secondary contamination is now much lower than it was a month ago.

Let's check this assumption with the latest available scientific and medical data.

The virus is less contagious now than it was a month ago.

Professor Didier Raoult on Radio classique, the political guest



To understand this phenomenon, we will take a look at the analysis of the mutations observed and their consequences in the expression of the virus in correlation with the observed symptoms.

For those requiring a better understanding  of what I'm going to talk about, I invite you to read or reread beforehand my article on covid  19 and its mutations. As I mentioned in this article, coronaviruses mutate regularly. These mutations are occurring at a lower frequency than for influenza viruses but sufficient to see many mutants appear.

Since the first genome of Covid19 was decoded, another 17,000 genomes have been sequenced to date and shared on the GISAID site, some of which carry distinctive mutations. It can also happen that during its mutations some accidents occur, such as losses of certain parts of the genome or in rarer cases, additions. 

As of April 2020, 33 distinct strains could be counted with slightly different characteristics from the conventional strain. Scientists, observed, that one of the mutants had acquired the ability to produce a viral load 270 times greater than the ancestral strain. Other teams found deletions (loss of part of the genome) on other strains of SARS-CoV-2 virus.

Was there a phase of increased contagiousness and severity of the virus?

Unfortunately, we have seen an increase in contagiousness and severity of the symptoms of the virus when the wave hit hard the European countries and New York.

How can we explain that the most serious cases would have been observed in Europe and New York?

  • The strains that attacked New Yorkers came largely from Europe

We have seen a more deadly attack of the virus in Europe and New York, compared to the Asian countries, which were first affected. In an article of "The New York Times", two distinct groups of researchers who worked on genomes came to the same conclusion. Most cases of New York coronavirus did indeed come from Europe where the epidemic severely affected populations.

  • More aggressive strains that can spread faster

A genetic analysis conducted on a sample of 103 SARS-CoV-2 genomes, indicated that these viruses evolved into two main types (designated L and S). The S-form, the ancestral version accounted for 30% of the genomes studied, while the L-type strain accounted for about 70%. The scientists concluded that human intervention may have exerted a more severe selective pressure on type L, resulting in a more aggressive form which is able to spread faster.

Another study showed that most of the sub-strains whose mutations were on the ORF8 and ORF1a genes (coding for two proteins) were found in patients outside Wuhan.

As a reminder, there are small systems in our cells capable of translating the messages contained in our genetic material and producing proteins that are assemblages of small units called amino acids.

Europeans and New Yorkers would therefore have had more virulent strains than those circulating at the beginning of the epidemic in China.

What do we know about the previous SARS outbreak?  

In 2003, during the SARS outbreak (with the SARS-CoV virus), a bell curve was observed with acceleration and regression as Professor Raoult mentioned.

During the progression of this epidemic, a number of genetic variants appeared in the human population as a result of unavoidable genetic mutations.

A large proportion of these viruses had mutations or deletions of genetic material in the gene "ORF8" encoding the protein "ORF8". And these mutations or deletions were associated with a reduced ability of the virus to replicate.

Towards the end of the SARS outbreak in 2003, genome sequences from viruses taken from the last infected patients were free of the gene encoding "ORF8", the latter having been removed from the genetic material of the original virus. This deletion may be associated with some form of host adaptation.

The same type of phenomenon has also been observed for batCoV (bats' SARS-CoV) viruses, with a similar disappearance of this fraction of the genome encoding for the protein "ORF8".

In a Chinese study, conducted on 63 samples (isolates) of SARS-CoV, the researchers noted major variations in the region of the viral genome where the ORF8 gene is located and also observed a correlation between the different phases of the epidemic and the different variations observed in this region of the genome.

They identified three phases:

The early phase: the first appearance period of SARS when the ORF8 gene was present.

The intermediate phase where mutations or deletions of more or less long nucleotide sequences were observed in the area of the ORF8 gene.

And the late phase where the ORF8 gene had completely disappeared from the genome, which seems to have signed the end of the SARS epidemic due to SARS-CoV.

During this human SARS outbreak, the removal of a fragment of the genome of 29 nucleotides from the ORF8 region appears to have occurred rapidly. Several mutants from Hong Kong patients have also seen a deletion of 386 nucleotides in the same region of the genome in some patients.

SARS-CoV-2 virus is close to SARS-CoV  (90%) and among their similarities, the presence of the spike protein (S) but also the ORF8 gene encoding protein 8 (which I call ORF8).

One could therefore assume that mutations and then the suppression of this part of the genome of SARS CoV-2, could explain the phenomenon of acceleration and regression of this epidemic disease, with an increasingly less virulent expression of the disease Covid-19, until its complete disappearance.

Discovery of a deletion of 382 nucleotides during the early evolution of SARS-CoV-2 (reference 6).

Discovery of a deletion of 382 nucleotides during the early evolution of SARS-CoV-2 (reference 6).

Has this type of mutation ever been observed for SARS-CoV-2?

Although mutations are weak in the region where genes are encoding ORF proteins in SARS CoV-2's genome, 13 variation sites have been identified by one research team, and among them, two sites (one in ORF8 and one in ORF1a) have shown high mutation rates (of around 30%).

In another pre-print article of March 12th, 2020, a Chinese team found a specific mutation on the viruses of eight patients hospitalized in Singapore. Indeed, the genome of SARS-CoV-2 that had contaminated them had a deletion of 382 nucleotides containing, among other things, the ORF8 gene, which is encoding the protein that intervenes in the replication of the virus.

They realized that the viruses, with this deletion, had been circulating since at least mid-February 2020. This may explain why the epidemic would have been better contained in Singapore and this part of the world, and not just through better pandemic management.

Is the key to the decline in contagiousness hidden in the area of the genome containing the ORF8 gene?

These results show that there may be selective mutations in SARS-CoV-2. Similar data on SARS-CoV, had suggested that the genetic variation in the region of the ORF8 gene was the result of viral adaptation.

In addition, in vivo studies in animals that have been inoculated with SARS-CoV have shown that the presence of the ORF8 gene induces higher average body temperature and stronger antibody responses than when it was absent, suggesting that the presence of the ORF8 gene (native or mutated) in humans may lead to a stronger immune response than in its absence.

In light of these different results, it would be interesting to sequence the genomes of the Covid-19 virus strains that have infected the latest patients to see if the region containing ORF8 has mutated or disappeared. This would eventually determine at what stage of the pandemic we are and validate the hypothesis that the pandemic curve would follow the evolution of the ORF8 gene.  

Further studies will be needed to validate the correlation between the evolution of this gene mutations and the increase then the decrease in contagiousness. If this is the case, this gene could serve as an indicator for future pandemics. One drug path could be to target this ORF8 protein to render it inactive or prevent it from being translated from the ORF8 gene.

In the meantime, there is a good chance that a mechanism of this nature might be happening.

When from the trench, you see the enemy withdrawing you have not yet won the war, but something happens.

Massimo Clementi, Director of the Laboratory of Microbiology and Virology at IRCCS Hospital San Raffaele in Milan

Is there a decrease in contagiousness and a reduction in symptoms?

As far as contagiousness is concerned, this seems to be the case, if we refer to the number of new infections in areas where people have been least contained in France. This is especially true in the northen subburbs of Paris region where an outbreak increase could have been expected. However, the numbers do not seem to have grown exponentially.

For the mitigation of symptoms, we will take a little tour on Italian side and the testimony of Massimo Clementi, bearing good news. Clementi is director of the Laboratory of Microbiology and Virology of the IRCCS Hospital San Raffaele in Milan, he has been interviewed by the daily quotidiano.net.

According to him, the profile of the infection is changing, compared to the first days of the tsunami. "When from the trench, you see the enemy withdrawing you have not yet won the war, but something is happening".

In March, intensive care units were full of patients arriving at the emergencies with respiratory failure requiring ventilation. We've seen a lot of deaths. Now, these situations are increasingly rare, as confirmed by the Civil Protection data."

In the US, the virus would travel from east to west, from coast to coast, while it would lose virulence during its mutations. For example, in Washington state in the western United States, where the epidemic occurred later, the strains would be less virulent.

It would appear that mutations and deletions in the area where the ORF8 gene is located may explain the phenomenon of acceleration and regression of this epidemic disease, as Professor Raoult suggested in his explanation of how epidemic diseases work. "The end of the game" would therefore be on track.

We now have good reason to hope and see the future in a more positive way, with the return to a life where joy can finally regain its full place.

But in the meantime, caution is advised. Continue to respect barrier gestures (frequent hand washing with soap or an alcohol-based solution, sneezing into your elbow or into a disposable tissue), wearing a mask and social distancing mesures because until we have scientific proof that the virus has indeed mutated to a benign form, we will have to maintain our vigilance.

Take care,



#covid19 #actucovid19 #genomecovid19 #mutationscovid19 #finpandemiecovid19 #geneORF8covid19



https://academic.oup.com/nsr/advance-article/doi/10.1093/nsr/nwaa036/5775463 https://www.radhttps://www.quotidiano.net/salute/coronavirus-news-1.5139665?fbclid=IwAR1_xCC_wsmkopZ7emndtLTo_EEzhpyUaA2pdOJSvsBnsyIRaQdIhfxnPCkioclassique.fr/magazine/articles/coronavirus-cest-en-train-de-seteindre-assure-didier-raoult/ https://www.gisaid.org/ https://www.nytimes.com/2020/04/08/science/new-york-coronavirus-cases-europe-genomes.html?fbclid=IwAR2TZDOzAs_2pv-FEfN2OrbaH29NWEJPA9GSMFZc4vM8tIjh55YJmEezeYs https://www.pourlascience.fr/sd/genetique/les-routes-du-covid-19-revelees-par-les-genes-19009.php https://www.researchgate.net/publication/339904520_Discovery_of_a_382-nt_deletion_during_the_early_evolution_of_SARS-CoV-2?fbclid=IwAR1hxpRdYIsRRZzxgEexABwG70FvM9nSM3HdsGwkY_8UQdmSWPtAos7eNjo https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161481/ https://www.ncbi.nlm.nih.gov/pubmed/32167180 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176222/ https://www.quotidiano.net/salute/coronavirus-news-1.5139665?fbclid=IwAR1_xCC_wsmkopZ7emndtLTo_EEzhpyUaA2pdOJSvsBnsyIRaQdIhfxnPCk https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176222/#CR47_12 https://renkulab.shinyapps.io/COVID-19-Epidemic-Forecasting/

Commenter cet article

La saga du Professeur Raoult et de son protocole à base d'hydroxychloroquine


Interview du professeur Didier Raoult du 19/05/2020

Comparaison des courbes épidémiques selon les villes et les pays.

Bulletin d'information scientifique de l'IHU - Nous avons le droit d'être intelligents ! Pr Didier Raoult, Directeur de l'IHU Méditerranée Infection




Interview du professeur Didier Raoult sur i24NEWS le 14/05/2020

Un visionnaire, une icône, un épidémiologiste de renommée mondiale qui a l'oreille des grands de ce monde mais qui a beaucoup d'ennemis.

Les meilleurs résultats de son traitement HQC + Azithromycine avec sa série.

"Les chiffres infléchissent, l'histoire est en train de vous donner raison, l'épidémie est en train de disparaître." 

Beaucoup de décideurs se sont positionnés comme s'ils étaient face à une maladie chronique, à réfléchir à la mise en place d'études pour valider quel traitement sera le plus efficace alors que la pandémie sera finie quand les résultats seront enfin disponibles.  Rôle de médecin de terrain avant tout, avec la prise en charge des malades. 

Repositionnement des molécules anciennes controversé car ne rapporte pas suffisamment à l'industrie pharmaceutique. Comment développer une molécule qui n'est plus rentable ?  

Un capital de molécules qui peuvent être utilisées comme azythromycine sur le Zika. On scie une branche de la science qui s'est développée depuis 20 ans et ce n'est pas vu de manière favorable. 

HCQ effet connu sur les autres maladies infectieuses respiratoires. 

Les média traditionnels (journaux et télévision) en conflit total avec les réseaux sociaux et youtube. Les média traditionnels identifient comme fake news des informations qui sont réelles et ils ne relayent pas plus de fausses informations que les réseaux sociaux. 

Lésions et séquelles chez les patients faiblement symptomatiques ou sans symptômes. Cela a aussi été étudié dans les deux autres épidémies de coronavirus. Il existe une discordance entre l'état clinique au départ et l'état des lésions des poumons. Risque d'évolution vers fibroses respiratoires (scanner à base dose). Il faut définir qui devrait pouvoir être diagnostiqué. Plan pour détecter les patients atteints afin de prévenir l'évolution des séquelles au niveau pulmonaire vers une fibrose. Il est possible de traiter si l'on intervient tôt.   

Pas de portage chronique du virus chez l'homme. Le virus peut circuler autour de la terre puis revenir, on pourrait peut être avoir des cas secondaires provenant d'Inde qui a eu un début d'épidémie décalé. Cette épidémie pourrait devenir saisonnière. On ne peut pas savoir.

C'est une maladie aiguë et immunisante car il y a une production d'anticorps.

"Bizarrement les gens qui vont mal ont beaucoup d'anticorps. Beaucoup plus tôt et en grande quantité. Ce serait donc pour ça que les traitements antiviraux programmés dans les dernières phases de la maladie ne seraient pas efficaces. Dans la phase finale de la maladie, le problème n'est plus lié au virus mais à la réponse immunitaire qui est très forte, violente (ndlr et disproportionnée)."  

La meilleure manière de lutter contre la transmission d'une infection respiratoire est avant tout lié au lavage des mains. Pour lui les masques sont indispensables pour le personnel soignant. C'est le lavage des mains qui prévient la maladie et protège de la contamination.



Interview du professeur Didier Raoult : Quelles leçons doit-on tirer de l'épidémie ?

- Des chiffres qui confirment la fin de l'épidémie.

- Réflexions sur la gestion de la crise et des stratégies thérapeutiques.

- Epidémie avec un virus que l'on ne connaissait pas et une maladie différente de celles observées jusqu'à présent.

- Plan pour détecter les patients atteints de séquelles au niveau des poumons (fibroses).  


Bulletin d'information scientifique de l'IHU - Nous avons le droit d'être intelligents ! Pr Didier Raoult, Directeur de l'IHU Méditerranée Infection




Interview du professeur Didier Raoult par Guillaume Durand sur Radio classique dans sa matinale du 05/05/2020




Des médecins américains affirment que l'hydroxychloroquine, médicament controversé aux USA et mis en lumière par Trump, aide 91% des patients atteints de coronavirus en facilitant leur récupération et en améliorant leurs chances de survie. Ils soutiennent qu'il ne faudrait pas attendre les données des "essais cliniques" vu les résultats largement positifs obtenus sur 2333 patients.  dailymail.co.uk




Ci-joint le lien pour aller voir l'excellente interview du professeur dans son intégralité. 

Des informations très pertinentes. A voir absolument. 



Articles récents

L'origine du COVID19 naturelle ou pas ? Que l'enquête commence...

Le professeur Luc Montagnier, prix Nobel de Médecine pour ses découvertes sur le virus du Sida, a lancé, il y a quelques jours un pavé dans la mare, qui a fait l'effet d'une bombe au niveau de la communauté scientifique quant à l'origine du virus et l'éventualité et l'éventualité qu'il puisse être issu d'une manipulation génétique.

Sa théorie selon laquelle il serait le produit de la manipulation d'un coronavirus auquel on aurait ajouté une séquence provenant du VIH, est venue relancer la thèse, largement relayée sur les réseaux sociaux, selon laquelle le virus aurait été créé dans un laboratoire P4 et qu'il s'en serait échappé par accident ou qu'il aurait été libéré intentionnellement. 

Image par Arek Socha de Pixabay

Dès le mois de mars nous avions eu des informations comme quoi l'origine pouvait être animale, via la chauve-souris, comme pour le SRAS CoV1. Puis le pangolin, ce petit animal en voie de disparition, dont les chinois sont friands, a, à son tour, été présenté comme un candidat potentiel. Mais l'hôte intermédiaire entre le pangolin et l'homme n'ayant pas été trouvé, les investigations se poursuivent. 

Nous allons enquêter sur ce sujet et voir comment progresse les différentes théories. Je vais vous faire une story avec une série d'articles, pour suivre, en temps réel, l'avancement des recherches et faire la lumière sur la véritable origine du covid19. 

Alors que l'enquête commence...

Take care,



Hébergé par Overblog